Feedback / Questions
sonelokimab (M1095) - Avillion, MoonLake Immunotherap
https://www.globenewswire.com/news-release/2026/02/02/3230183/0/en/MoonLake-Announces-FDA-Fast-Track-Designation-for-Sonelokimab-Palmoplantar-Pustulosis-PPP-and-Provides-Details-on-Upcoming-Investor-Day.html
Feb 2, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next